Developer docs
API playgroundTry for free, no card

Search company profiles

Bengay

Full company profile

uuid002l6cx

Namestring
Bengay
Legal namestring
Kenvue Brands LLC
Websiteurl
bengay.com
Company typeenum
Private
Founded yearint
1898
Descriptiontext

BENGAY is a heritage American over-the-counter (OTC) topical analgesic brand founded in 1898 and now owned by Kenvue Brands LLC, a subsidiary of Kenvue Inc. (NYSE: KNVU, formerly Johnson & Johnson Consumer Health). The brand markets four core SKU formats—Ultra Strength Non-Greasy Cream (4% camphor, 10% menthol, 30% methyl salicylate), Ultra Strength Pain Relieving Patch (5% menthol), 4% Lidocaine Tropical Jasmine Cream, and Vanishing Scent Gel (2.5% menthol)—all of which deliver temporary, localized relief for minor muscle aches, joint pain, backache, arthritis, strains, bruises, and sprains by desensitizing nerves or blocking pain perception at the site of application rather than through systemic absorption. The technology is fundamentally pharmaceutical/formulation-based rather than digital, with each format using FDA-monographed OTC active ingredients and proprietary combinations differentiated by strength, scent, and non-greasy delivery.

The business operates as a consumer packaged goods (CPG) brand rather than a standalone company. Revenue is generated through one-time retail purchases of OTC products at pharmacies, drug stores, mass retail chains, and grocery stores across the United States, distributed via Kenvue's established consumer health wholesale network. Pricing is set at retail and is not publicly disclosed on the BENGAY website. The go-to-market motion is direct-to-consumer in spirit but executed at point-of-sale through mass retail, supported by content marketing (bengay.com's Understanding Pain and Sore Spotter tools), SEO, organic social, couponing, and physician-recommendation positioning that leverages the brand's 125+ year heritage and its claim as the #1 doctor-recommended topical pain relief brand. Primary customer segments are athletes and fitness enthusiasts experiencing post-exercise soreness, arthritis sufferers (often 54+ years), and general consumers with everyday minor aches and pains, with the brand pursuing a horizontal segmentation approach across these use cases.

Short descriptiontext

BENGAY is a 125+ year-old American OTC topical analgesic brand owned by Kenvue Brands LLC, selling menthol-, camphor-, and lidocaine-based creams, gels, and patches for temporary muscle and joint pain relief through U.S. mass retail, targeting athletes, arthritis sufferers, and general consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLakewood, United States
HQ citystring
Lakewood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
topical pain relief, muscle and joint analgesics, over-the-counter pain cream, OTC menthol patches, arthritis pain relief
Industry2 codes
PRIMARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code3 codes
  • Pharmacies and Drug Retailers456110
  • Health and Personal Care Retailers456
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code3 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Retail-Drug Stores And Proprietary Stores5912
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Topical Analgesics / OTC Pain Relief
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1OTC Topical Analgesic Products
TypeHardware Sales
Description

BENGAY generates revenue through the sale of topical pain relief products (creams, gels, patches) at retail pharmacies and stores. Products are sold as one-time purchases at varying price points depending on product type and size. The brand operates as a consumer packaged goods (CPG) business with distribution through mass retail, drug stores, and potentially e-commerce channels.

bengay.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bengay sells over-the-counter topical analgesic products (creams, gels, and patches) formulated with menthol, camphor, methyl salicylate, and lidocaine to provide temporary relief of minor muscle and joint pain, simple backache, arthritis pain, strains, bruises, and sprains. Products are sold as one-time purchases through mass retail, drug stores, and pharmacies in the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Temporary relief of minor aches and pains of muscles and joints
Product overview1 text field

BENGAY® is a Physician-recommended OTC (over-the-counter) topical analgesic brand offering four distinct pain relief products: Ultra Strength Non-Greasy Cream (with 4% camphor, 10% menthol, 30% methyl salicylate), Ultra Strength Pain Relieving Patch (5% menthol), 4% Lidocaine Tropical Jasmine Cream (numbing formula), and Vanishing Scent Gel (2.5% menthol). The product portfolio uses three delivery formats—creams, patches, and gels—to provide localized, temporary relief of minor aches and pains associated with simple backache, arthritis, strains, bruises, sprains, and muscle pain. Products work by temporarily blocking the perception of pain at the site of application and are absorbed directly into the affected area.

Product and service1 record
1Ultra Strength BENGAY® Non-Greasy Topical Pain Relief Cream
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Kenvue Brands LLC is the parent company and site owner of BENGAY. The website is published by Kenvue Brands LLC, which is solely responsible for its contents. BENGAY operates as part of Kenvue's consumer health brands portfolio.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Performance Health's menthol-based topical analgesic brand sold in sprays, roll-ons, creams, and patches through the same pharmacy and mass retail channels, directly competing for the same athlete and arthritis use cases.

TypeDirect peer
Description

Chattem/Sanofi's lidocaine-based topical analgesic line, directly comparable to Bengay's 4% Lidocaine Tropical Jasmine Cream, targeting arthritis and joint pain consumers in the same retail channels.

TypeDirect peer
Description

Haw Par Corporation's heritage topical analgesic brand with camphor and menthol formulations, competing in the same OTC pain relief category across drug stores and mass retail.

TypeDirect peer
Description

Chattem/Sanofi's flagship topical analgesic brand and Bengay's closest direct competitor, offering similar menthol-based creams, patches, and sprays for muscle and joint pain across the same OTC retail channels.

TypeDirect peer
Description

Hisamitsu's OTC topical pain relief brand, a patch-format leader, competing with Bengay in patches and OTC topical analgesics across US drug and mass retail.

TypeBroad incumbent
Description

Post-GSK consumer health spinoff owning Voltaren, Advil, and other OTC pain brands, providing a broad incumbent portfolio with overlapping topical analgesic offerings and global distribution versus Bengay's US-only footprint.

TypeEmerging player
Description

Direct-to-consumer topical analgesic cream focused on joint and inflammation relief, comparable to Bengay in active ingredient profile (arnica, methylsulfonylmethane) and target use cases but with a digital-first GTM.

TypeDirect peer
Description

McPharma's topical analgesic brand featuring emu oil and trolamine salicylate, sold through the same mass and drug retail channels targeting muscle and joint pain.

TypeEmerging player
Description

AVM Health's specialized topical spray for muscle cramps and spasms, competing in adjacent use cases (athletic recovery, nighttime leg cramps) within the same OTC analgesic category.

10Voltaren (topical)
TypeDirect peer
Description

GSK/Haleon's topical NSAID (diclofenac) brand for arthritis pain, offering a differentiated mechanism (anti-inflammatory) versus Bengay's counterirritant approach in the same consumer use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bengay

Topical Analgesics / OTC Pain Reliefbengay.com

BENGAY is a 125+ year-old American OTC topical analgesic brand owned by Kenvue Brands LLC, selling menthol-, camphor-, and lidocaine-based creams, gels, and patches for temporary muscle and joint pain relief through U.S. mass retail, targeting athletes, arthritis sufferers, and general consumers.

What Bengay does

BENGAY is a heritage American over-the-counter (OTC) topical analgesic brand founded in 1898 and now owned by Kenvue Brands LLC, a subsidiary of Kenvue Inc. (NYSE: KNVU, formerly Johnson & Johnson Consumer Health). The brand markets four core SKU formats—Ultra Strength Non-Greasy Cream (4% camphor, 10% menthol, 30% methyl salicylate), Ultra Strength Pain Relieving Patch (5% menthol), 4% Lidocaine Tropical Jasmine Cream, and Vanishing Scent Gel (2.5% menthol)—all of which deliver temporary, localized relief for minor muscle aches, joint pain, backache, arthritis, strains, bruises, and sprains by desensitizing nerves or blocking pain perception at the site of application rather than through systemic absorption. The technology is fundamentally pharmaceutical/formulation-based rather than digital, with each format using FDA-monographed OTC active ingredients and proprietary combinations differentiated by strength, scent, and non-greasy delivery.

The business operates as a consumer packaged goods (CPG) brand rather than a standalone company. Revenue is generated through one-time retail purchases of OTC products at pharmacies, drug stores, mass retail chains, and grocery stores across the United States, distributed via Kenvue's established consumer health wholesale network. Pricing is set at retail and is not publicly disclosed on the BENGAY website. The go-to-market motion is direct-to-consumer in spirit but executed at point-of-sale through mass retail, supported by content marketing (bengay.com's Understanding Pain and Sore Spotter tools), SEO, organic social, couponing, and physician-recommendation positioning that leverages the brand's 125+ year heritage and its claim as the #1 doctor-recommended topical pain relief brand. Primary customer segments are athletes and fitness enthusiasts experiencing post-exercise soreness, arthritis sufferers (often 54+ years), and general consumers with everyday minor aches and pains, with the brand pursuing a horizontal segmentation approach across these use cases.

Bengay firmographics

Firmographics
Name
Bengay
Legal name
Kenvue Brands LLC
Website
https://bengay.com
Company type
Private
Founded year
1898
Operating status
Operating
Headcount range
1–10 employees
Short description
BENGAY is a 125+ year-old American OTC topical analgesic brand owned by Kenvue Brands LLC, selling menthol-, camphor-, and lidocaine-based creams, gels, and patches for temporary muscle and joint pain relief through U.S. mass retail, targeting athletes, arthritis sufferers, and general consumers.
Ownership category
akta.pro rank

Bengay industry classification

Industry
Product category
Topical Analgesics / OTC Pain Relief
NAICS
Pharmacies and Drug Retailers (456110), Health and Personal Care Retailers (456), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Topical pain relief
  • Muscle and joint analgesics
  • Over-the-counter pain cream
  • OTC menthol patches
  • Arthritis pain relief

Where Bengay is headquartered

Location

Headquarters

HQ city
Lakewood
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bengay business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel

Revenue model

  1. OTC Topical Analgesic Products: BENGAY generates revenue through the sale of topical pain relief products (creams, gels, patches) at retail pharmacies and stores. Products are sold as one-time purchases at varying price points depending on product type and size. The brand operates as a consumer packaged goods (CPG) business with distribution through mass retail, drug stores, and potentially e-commerce channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Bengay product offering

Product offering

Core offering

Bengay sells over-the-counter topical analgesic products (creams, gels, and patches) formulated with menthol, camphor, methyl salicylate, and lidocaine to provide temporary relief of minor muscle and joint pain, simple backache, arthritis pain, strains, bruises, and sprains. Products are sold as one-time purchases through mass retail, drug stores, and pharmacies in the United States.

Product overview

BENGAY® is a Physician-recommended OTC (over-the-counter) topical analgesic brand offering four distinct pain relief products: Ultra Strength Non-Greasy Cream (with 4% camphor, 10% menthol, 30% methyl salicylate), Ultra Strength Pain Relieving Patch (5% menthol), 4% Lidocaine Tropical Jasmine Cream (numbing formula), and Vanishing Scent Gel (2.5% menthol). The product portfolio uses three delivery formats—creams, patches, and gels—to provide localized, temporary relief of minor aches and pains associated with simple backache, arthritis, strains, bruises, sprains, and muscle pain. Products work by temporarily blocking the perception of pain at the site of application and are absorbed directly into the affected area.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ultra Strength BENGAY® Non-Greasy Topical Pain Relief Cream

Quantifiable outcome

  • Temporary relief of minor aches and pains of muscles and joints

Companies that use Bengay

Customer profile

Segments4 records

Ideal customer profiles4 records

Bengay technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Bengay partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Kenvue Brands LLCcoreOthersKenvue Brands LLC is the parent company and site owner of BENGAY. The website is published by Kenvue Brands LLC, which is solely responsible for its contents. BENGAY operates as part of Kenvue's consumer health brands portfolio.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Bengay competitors and assessment

Company assessment

Direct peers

  • Biofreeze: Performance Health's menthol-based topical analgesic brand sold in sprays, roll-ons, creams, and patches through the same pharmacy and mass retail channels, directly competing for the same athlete and arthritis use cases.
  • Aspercreme: Chattem/Sanofi's lidocaine-based topical analgesic line, directly comparable to Bengay's 4% Lidocaine Tropical Jasmine Cream, targeting arthritis and joint pain consumers in the same retail channels.
  • Tiger Balm: Haw Par Corporation's heritage topical analgesic brand with camphor and menthol formulations, competing in the same OTC pain relief category across drug stores and mass retail.
  • Icy Hot: Chattem/Sanofi's flagship topical analgesic brand and Bengay's closest direct competitor, offering similar menthol-based creams, patches, and sprays for muscle and joint pain across the same OTC retail channels.
  • Salonpas: Hisamitsu's OTC topical pain relief brand, a patch-format leader, competing with Bengay in patches and OTC topical analgesics across US drug and mass retail.
  • Blue-Emu: McPharma's topical analgesic brand featuring emu oil and trolamine salicylate, sold through the same mass and drug retail channels targeting muscle and joint pain.
  • Voltaren (topical): GSK/Haleon's topical NSAID (diclofenac) brand for arthritis pain, offering a differentiated mechanism (anti-inflammatory) versus Bengay's counterirritant approach in the same consumer use cases.

Broad incumbents

  • Haleon (consumer health): Post-GSK consumer health spinoff owning Voltaren, Advil, and other OTC pain brands, providing a broad incumbent portfolio with overlapping topical analgesic offerings and global distribution versus Bengay's US-only footprint.

Emerging players

  • Penetrex: Direct-to-consumer topical analgesic cream focused on joint and inflammation relief, comparable to Bengay in active ingredient profile (arnica, methylsulfonylmethane) and target use cases but with a digital-first GTM.
  • Theraworx Relief: AVM Health's specialized topical spray for muscle cramps and spasms, competing in adjacent use cases (athletic recovery, nighttime leg cramps) within the same OTC analgesic category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Bengay financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bengay leadership team

Management profile

Number of profiles

Profiles1 record

Bengay funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bengay M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bengay

What does Bengay do?

Bengay sells over-the-counter topical analgesic products (creams, gels, and patches) formulated with menthol, camphor, methyl salicylate, and lidocaine to provide temporary relief of minor muscle and joint pain, simple backache, arthritis pain, strains, bruises, and sprains. Products are sold as one-time purchases through mass retail, drug stores, and pharmacies in the United States.

Is Bengay a public or private company?

Bengay is a private company. It is classified as corporate owned and is currently operating.

When was Bengay founded?

Bengay was founded in 1898. It employs 1 to 10 people.

Where is Bengay based?

Bengay is headquartered in Lakewood, United States, in the North America region.

How does Bengay make money?

One revenue line is on record: OTC Topical Analgesic Products.

Who are Bengay's main competitors?

Direct peers on record are Biofreeze, Aspercreme, Tiger Balm, Icy Hot, Salonpas, Blue-Emu and Voltaren (topical). Haleon (consumer health) is listed as a broad incumbent. Emerging players are Penetrex and Theraworx Relief.

Does Bengay have an API?

No public API is recorded for Bengay.

What industry is Bengay in?

Bengay's product category is Topical Analgesics / OTC Pain Relief. Its primary akta.pro industry code is CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief), with a secondary code of HLAIADAA, Pain Relief & Anti-Inflammatory (Analgesics). Its NAICS code is 456110 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales